Intra-arterial Papaverine Dosing for Post-Vascular Repair Spasm
For post-vascular repair arterial spasm, administer 30-60 mg papaverine intra-arterially as a slow infusion over 1-2 minutes, with a maximum total dose of 300 mg per vascular territory if repeat dosing is needed.
Dosing Algorithm
The optimal papaverine dose depends on the vessel size and location:
Standard Peripheral Vascular Territory
- Initial dose: 30-60 mg diluted in saline
- Concentration: 0.3-0.4% (weight/volume) solution
- Administration rate: Slow infusion over 1-2 minutes to avoid systemic effects
- Maximum total dose: 300 mg per vascular territory 1
Vessel-Specific Dosing (from coronary literature, applicable to similar-sized vessels)
- Larger vessels (comparable to left coronary): 15 mg 2
- Smaller vessels (comparable to right coronary): 10 mg 2
Concentration Considerations
The evidence strongly supports 0.4% (w/v) concentration as the optimal balance between efficacy and safety 3. This translates to:
- 80 mg papaverine in 20 mL saline infused over 10 minutes
- Lower concentrations (0.1-0.2%) showed reduced efficacy (only 80% success vs. higher concentrations)
- Higher concentrations (0.8-2.0%) carried significantly increased risk of transient neurological deficits (44% vs. 6%) 3
Administration Technique
Critical technical points:
- Inject slowly over 1-2 minutes when immediate effect is desired 4
- For sustained infusion: use 3 mg/mL concentration at 6-9 mL/min 1
- Position catheter as close to the spastic segment as possible for adequate drug delivery 5
- Do not use guiding catheters with side holes 2
Repeat Dosing Protocol
If initial treatment is inadequate:
- Wait 3 hours before repeat administration 4
- Can repeat every 3 hours as indicated
- Monitor cumulative dose (maximum 300 mg per territory) 1, 6
Critical Safety Monitoring
Monitor continuously during and after administration:
Cardiovascular Effects
- QT prolongation and T-wave abnormalities are common 2
- Rare but serious: ventricular tachycardia or torsade de pointes 2
- Bradycardia and hypotension can occur, especially with rapid infusion 7
Neurological Effects (if treating cerebral vessels)
- Increased intracranial pressure is expected 7
- Transient focal deficits occur in 6-7% at appropriate concentrations 3
- Risk increases to 44% with highly concentrated solutions 3
Duration of Effect
- Hyperemic response lasts 60-90 seconds (4 times longer than adenosine) 2
- Half-life approximately 2 minutes 2
Important Caveats
Papaverine is NOT the preferred first-line agent for coronary vasospasm due to safety concerns—adenosine is preferred in that setting 2. However, for peripheral vascular spasm post-repair, papaverine remains a reasonable option given the FDA indication for "vascular spasm associated with acute myocardial infarction, peripheral and pulmonary embolism, peripheral vascular disease" 4.
Avoid in patients with:
- Prolonged QT syndrome
- Recent ventricular arrhythmias
- Complete heart block (without pacemaker)
The evidence base is primarily from cerebrovascular and coronary applications, but the principles translate to peripheral vascular spasm. The 300 mg maximum per territory is well-established in neurovascular literature 1, 6 and represents the safest upper limit with documented efficacy.